SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Medicus Pharma Regains Nasdaq Bid-Price Compliance

Medicus Pharma says it has regained compliance with Nasdaq’s minimum bid-price requirement.

MDCX

Story updates

11:37:04 AM UTC
SquawkNews
Medicus received notice from Nasdaq that it regained compliance with the $1.00 minimum bid price after 10 consecutive trading days at or above $1.00.Material DetailsContext by AI AnalystThis is a corrective listing update after a prior bid-price deficiency, not a change in fundamentals. A larger ca…

Related stories